NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
NGM Biopharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Execu...